»  Search

 


Advanced search



»  Quick Links




»  Contact

B·R·A·H·M·S Aktiengesellschaft
Neuendorfstrasse 25
D-16761 Hennigsdorf

Tel: +49 - 3302 - 883 - 0
Fax: +49 - 3302 - 883 - 100



Customer service
Our customer service offers you extensive support and information regarding our products and services continue
Distribution
We distribute our products in over 65 countries around the world. Find your B·R·A·H·M·S contact in your country here. continue
Products
Choose the optimum solution for your diagnostic problem from our product range of around 40 special in vitro parameters continue


News
1/29/2010 - Personnel Announcement

Albert J. Jonker will leave B·R·A·H·M·S Aktiengesellschaft to the 31st of January 2010 on his own wish. As Chief Finance Officer and co-owner he has been shaping B·R·A·H·M·S since 2001 and essentially contributed to the growth of the corporation.

11/24/2009 - B·R·A·H·M·S-Forum: Workshop on thyroid cancer big success

Hennigsdorf / Berlin 24.11.2009. At the invitation of B·R·A·H·M·S over 50 medics and scientists made their way to Berlin on November 6 and 7 to get an update on most recent developments in the field of thyroid cancer.

10/1/2009 - Competition Authorities approve Acquisition of B·R·A·H·M·S by Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) has acquired all of the shares of B·R·A·H·M·S Holding GmbH. The contractual merger resulting from this transaction was announced at the beginning of September. After a four-week inspection, the competent supervisory authorities have now also consented to the agreement.

9/15/2009 - The struggle against bacterial resistance and increasing medical costs:

ProHOSP study demonstrates the value of Procalcitonin marker for lower respiratory tract infections

9/3/2009 - B·R·A·H·M·S and Thermo Fischer Scientific join forces to create a leader in specialty diagnostics.

B·R·A·H·M·S announces the signature of a Share Purchase Agreement (SPA) with Thermo Fisher Scientific Inc. (NYSE: TMO) for 100% of the share capital of B·R·A·H·M·S Holding GmbH in the amount of EUR 330 million (approx. USD 470 million) including debt and other liabilities. The transaction, which is subject to applicable regulatory approvals, is expected to be closed in late September.

Dates
Financial calendar
Release dates for information regarding the company's financial situation
Conventions & events
Conventions and events where you will find us


This website is outside the U.S.
Products and/or uses listed may not be available to our customers in the U.S.
Please visit our US Website
http://www.brahms-usa.com for detailed information on product availability in the U.S.